Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Chylothorax	FAT4 RASA1 TSC1 MAP2K1	1.36e-05	18	44	4	HP:0010310
HumanPheno	Noncommunicating hydrocephalus	DLG5 BICRA TSC1	3.27e-05	8	44	3	HP:0010953
HumanPheno	Neoplasm of striated muscle	NBN TSC1 DICER1 NF1	5.37e-05	25	44	4	HP:0009728
HumanPheno	Abnormal pulmonary valve physiology	FAT4 KAT6A MUC5B ZEB2 ZNF469 NF1 MAP2K1 KDM6A	6.14e-05	163	44	8	HP:0031654
HumanPheno	Neoplasm by histology	FAT4 APC2 NBN NLRP1 TSC1 DCC DICER1 ZEB2 BLM NF1 MAP2K1 IL6ST	6.35e-05	383	44	12	HP:0011792
MousePheno	increased classified tumor incidence	AIRE NBN TSC1 CHD2 DCC BLM HIVEP3 RINT1 NF1 TPX2 IL6ST TP53BP2	2.31e-05	381	103	12	MP:0010273
MousePheno	abnormal classified tumor incidence	AIRE NBN TSC1 CHD2 DCC BLM HIVEP3 RINT1 NF1 TPX2 IL6ST TP53BP2	2.50e-05	384	103	12	MP:0020188
MousePheno	increased lymphoma incidence	AIRE NBN CHD2 BLM RINT1 NF1 TPX2 TP53BP2	2.80e-05	164	103	8	MP:0012431
MousePheno	increased muscle tumor incidence	TSC1 RINT1 TP53BP2	3.16e-05	9	103	3	MP:0010290
MousePheno	abnormal thymus epithelium morphology	AIRE TNFRSF11A LTBR	8.14e-05	12	103	3	MP:0009544
MousePheno	increased hemolymphoid system tumor incidence	AIRE NBN CHD2 BLM RINT1 NF1 TPX2 TP53BP2	8.24e-05	191	103	8	MP:0010296
MousePheno	abnormal heart septum morphology	FAT4 BICRA KAT6A RDH10 ADCY9 NF1 XIRP2 WDFY3 KLK2 KDM6A TP53BP2	1.32e-04	388	103	11	MP:0006113
MousePheno	increased tumor incidence	AIRE SPART NBN TSC1 CHD2 DCC BLM HIVEP3 RINT1 NF1 TPX2 IL6ST TP53BP2	1.36e-04	530	103	13	MP:0002020
MousePheno	abnormal adenoma incidence	NBN TSC1 DCC RINT1 TPX2 IL6ST	1.59e-04	110	103	6	MP:0020189
MousePheno	increased adenoma incidence	NBN TSC1 DCC RINT1 TPX2 IL6ST	1.59e-04	110	103	6	MP:0010383
MousePheno	increased cystadenoma incidence	TSC1 RINT1	1.61e-04	3	103	2	MP:0013751
MousePheno	increased leiomyoma incidence	TSC1 RINT1	1.61e-04	3	103	2	MP:0003569
MousePheno	increased uterus leiomyoma incidence	TSC1 RINT1	1.61e-04	3	103	2	MP:0003570
Domain	Znf_FYVE_PHD	TCF20 PCLO KAT6A SYTL2 AIRE MTMR4 WDFY3 FGD6	5.84e-06	147	123	8	IPR011011
Domain	SH3	DLG5 RASA1 SH3D21 DOCK5 TJP1 SH3D19 SH3RF3 TP53BP2	9.27e-05	216	123	8	SM00326
Domain	SH3	DLG5 RASA1 SH3D21 DOCK5 TJP1 SH3D19 SH3RF3 TP53BP2	9.27e-05	216	123	8	PS50002
Domain	SH3_domain	DLG5 RASA1 SH3D21 DOCK5 TJP1 SH3D19 SH3RF3 TP53BP2	1.05e-04	220	123	8	IPR001452
Domain	NUT	NUTM2G NUTM2F	4.25e-04	5	123	2	IPR024310
Domain	NUT_N	NUTM2G NUTM2F	4.25e-04	5	123	2	IPR024309
Domain	NUT	NUTM2G NUTM2F	4.25e-04	5	123	2	PF12881
Domain	CLIC	CLIC6 CLIC2	6.34e-04	6	123	2	IPR002946
Domain	PIN_dom	NOB1 DIS3	6.34e-04	6	123	2	IPR002716
Domain	PINc	NOB1 DIS3	6.34e-04	6	123	2	SM00670
Domain	FYVE	MTMR4 WDFY3 FGD6	8.99e-04	29	123	3	PF01363
Domain	FYVE	MTMR4 WDFY3 FGD6	8.99e-04	29	123	3	SM00064
Domain	Znf_FYVE-rel	MTMR4 WDFY3 FGD6	1.44e-03	34	123	3	IPR017455
Domain	DNA/RNA_helicase_DEAH_CS	EP400 CHD2 BLM	1.56e-03	35	123	3	IPR002464
Domain	Znf_FYVE	MTMR4 WDFY3 FGD6	1.99e-03	38	123	3	IPR000306
Domain	DEAH_ATP_HELICASE	EP400 CHD2 BLM	1.99e-03	38	123	3	PS00690
Domain	ZF_FYVE	MTMR4 WDFY3 FGD6	2.31e-03	40	123	3	PS50178
Domain	H15	KAT6A HP1BP3	3.20e-03	13	123	2	SM00526
Domain	H15	KAT6A HP1BP3	3.20e-03	13	123	2	PS51504
Domain	Histone_H1/H5_H15	KAT6A HP1BP3	3.72e-03	14	123	2	IPR005818
Domain	RasGAP	RASA1 NF1	3.72e-03	14	123	2	SM00323
Domain	RasGAP_CS	RASA1 NF1	3.72e-03	14	123	2	IPR023152
Domain	RasGAP	RASA1 NF1	4.27e-03	15	123	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA1 NF1	4.27e-03	15	123	2	PS00509
Domain	Spectrin_alpha_SH3	SH3D21 TP53BP2	4.27e-03	15	123	2	IPR013315
Domain	RAS_GTPASE_ACTIV_2	RASA1 NF1	4.27e-03	15	123	2	PS50018
Domain	fn3	ABI3BP SPEG DCC IL6ST MYBPC3	4.39e-03	162	123	5	PF00041
Domain	SH3_1	RASA1 DOCK5 SH3D19 SH3RF3 TP53BP2	4.62e-03	164	123	5	PF00018
Domain	Post-SET_dom	SETD1A SETDB1	4.86e-03	16	123	2	IPR003616
Domain	PostSET	SETD1A SETDB1	4.86e-03	16	123	2	SM00508
Domain	POST_SET	SETD1A SETDB1	4.86e-03	16	123	2	PS50868
Domain	Helicase_C	EP400 CHD2 DICER1 BLM	5.49e-03	107	123	4	PF00271
Domain	HELICc	EP400 CHD2 DICER1 BLM	5.49e-03	107	123	4	SM00490
Domain	Helicase_C	EP400 CHD2 DICER1 BLM	5.67e-03	108	123	4	IPR001650
Domain	HELICASE_CTER	EP400 CHD2 DICER1 BLM	5.86e-03	109	123	4	PS51194
Domain	HELICASE_ATP_BIND_1	EP400 CHD2 DICER1 BLM	5.86e-03	109	123	4	PS51192
Domain	DEXDc	EP400 CHD2 DICER1 BLM	5.86e-03	109	123	4	SM00487
Domain	Helicase_ATP-bd	EP400 CHD2 DICER1 BLM	6.05e-03	110	123	4	IPR014001
Domain	RasGAP_dom	RASA1 NF1	6.14e-03	18	123	2	IPR001936
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP53 TFEB DLG5 TCF20 KIF26B SEC24A PTK2B VPS13D MTMR4 NF1 DCP1B TJP1 SH3D19 MAP2K1 FGD6 SH3RF3 TP53BP2 MAP3K2	3.03e-09	861	128	18	36931259
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	USP53 SETD1A EP400 BICRA APC2 NUP214 SH3D21 MS4A10 DOCK5 ZNF469 XIRP2 TPX2 TP53BP2	7.71e-09	430	128	13	35044719
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	SETD1A NBN BLM KDM6A	5.15e-07	18	128	4	17500065
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GNL3L TCF20 EP400 SYTL2 NBN TSC1 NUP214 DICER1 ADCY9 SETDB1 MTMR4 DCP1B TJP1 TPX2	5.74e-07	733	128	14	34672954
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SETD1A TCF20 EP400 SF3A1 NBN DIS3 HP1BP3 NDC1 TPX2 INTS9	5.87e-07	341	128	10	32971831
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TFEB SETD1A CRYBG2 MAN2A2 EP400 BICRA SPEG GRK6 KAT6A NOB1 RDH10 NUP214 ADCY9 HIVEP3 WDFY3 MYRF ABCC10	6.78e-07	1105	128	17	35748872
Pubmed	Human transcription factor protein interaction networks.	SETD1A TCF20 EP400 BICRA SEC24A ZBTB9 GCM1 NBN NUP214 DBN1 ZEB2 HP1BP3 BLM SETDB1 DCP1B TPX2 MRPS15 DLAT KDM6A	1.26e-06	1429	128	19	35140242
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	TCF20 EP400 ZBTB9 NBN ZNF518A BLM TPX2 SENP6	1.80e-06	222	128	8	37071664
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GNL3L EP400 SF3A1 SPART NBN TSC1 NUP214 DBN1 DIS3 HP1BP3 TJP1 SH3D19 TPX2 SENP6 TP53BP2	1.92e-06	934	128	15	33916271
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TCF20 EP400 RBL1 BICRA PCLO NLRP1 ZEB2 ZNF518A NUTM2F KDM6A	2.35e-06	398	128	10	35016035
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GNL3L SPEG TSC1 CHD2 NUP214 HP1BP3 BLM VPS13D XIRP2 ASCC2 SH3RF3	2.46e-06	497	128	11	36774506
Pubmed	Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.	KAT6A NLRP1 DCC HP1BP3 BLM PTK2B GZMB DLAT TP53BP2	2.58e-06	313	128	9	20800603
Pubmed	Lymphotoxin signal promotes thymic organogenesis by eliciting RANK expression in the embryonic thymic stroma.	AIRE TNFRSF11A LTBR	2.69e-06	8	128	3	21441458
Pubmed	Identification of embryonic precursor cells that differentiate into thymic epithelial cells expressing autoimmune regulator.	AIRE TNFRSF11A LTBR	2.69e-06	8	128	3	27401343
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DLG5 TCF20 POLD2 ZBTB9 SPART NUP214 DICER1 INTS9	3.41e-06	242	128	8	34011540
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GNL3L EP400 RBL1 BICRA TPRN KAT6A SPTLC1 ZBTB9 NBN DICER1 ADCY9 ZNF518A SETDB1 ZNF469 DLAT WDFY3	3.66e-06	1116	128	16	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TCF20 EP400 SF3A1 NBN NUP214 DBN1 BLM NF1 GZMB TPX2 SENP6 APPL1 KDM6A	6.01e-06	774	128	13	15302935
Pubmed	p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons.	NF1 MAP2K1 KLK2	7.86e-06	11	128	3	9852579
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	USP53 ZNF444 GNL3L RASA1 ERV3-1 BICRA WASF3 KAT6A RDH10 CHD2 HP1BP3 DOCK5 HIVEP3 PTPRE TJP1 LTBR SH3RF3 KDM6A	9.15e-06	1489	128	18	28611215
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TFEB DLG5 EP400 TPRN SPART NBN TSC1 DIS3 BLM SETDB1 SENP6	1.20e-05	588	128	11	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	TPRN SYTL2 SPART ZEB2 ZNF518A SETDB1 MTMR4 DCP1B ASCC2 KDM6A TP53BP2	1.26e-05	591	128	11	15231748
Pubmed	MicroRNAs are indispensable for reprogramming mouse embryonic fibroblasts into induced stem cell-like cells.	KIF26B DICER1	1.34e-05	2	128	2	22737231
Pubmed	Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes.	GZMH GZMB	1.34e-05	2	128	2	3485287
Pubmed	RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.	RASA1 NF1	1.34e-05	2	128	2	29127119
Pubmed	Granzyme B in injury, inflammation, and repair.	GZMH GZMB	1.34e-05	2	128	2	23099058
Pubmed	A novel lineage-specific hypersensitive site is essential for position independent granzyme B expression in transgenic mice.	GZMH GZMB	1.34e-05	2	128	2	18222115
Pubmed	p120RasGAP Protein Mediates Netrin-1 Protein-induced Cortical Axon Outgrowth and Guidance.	RASA1 DCC	1.34e-05	2	128	2	26710849
Pubmed	APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.	APC2 TP53BP2	1.34e-05	2	128	2	10646860
Pubmed	Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma.	GZMH GZMB	1.34e-05	2	128	2	33737344
Pubmed	Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.	GZMH GZMB	1.34e-05	2	128	2	22017873
Pubmed	Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs.	GZMH GZMB	1.34e-05	2	128	2	18836177
Pubmed	Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C).	GZMH GZMB	1.34e-05	2	128	2	2402757
Pubmed	Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells.	GZMH GZMB	1.34e-05	2	128	2	16901729
Pubmed	Discordant regulation of granzyme H and granzyme B expression in human lymphocytes.	GZMH GZMB	1.34e-05	2	128	2	15069086
Pubmed	The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing.	GZMH GZMB	1.34e-05	2	128	2	21177822
Pubmed	Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse.	GZMH GZMB	1.34e-05	2	128	2	32696761
Pubmed	Metallophilic macrophages are fully developed in the thymus of autoimmune regulator (Aire)-deficient mice.	AIRE LTBR	1.34e-05	2	128	2	19148669
Pubmed	Requirement of MHC class I on radioresistant cells for granzyme B expression from CD8+ T cells in murine contact hypersensitivity.	GZMH GZMB	1.34e-05	2	128	2	29428817
Pubmed	Granzyme B deficiency exacerbates lung inflammation in mice after acute lung injury.	GZMH GZMB	1.34e-05	2	128	2	23642129
Pubmed	Novel serine proteases encoded by two cytotoxic T lymphocyte-specific genes.	GZMH GZMB	1.34e-05	2	128	2	3518058
Pubmed	Structure and evolutionary origin of the human granzyme H gene.	GZMH GZMB	1.34e-05	2	128	2	2049336
Pubmed	Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation.	GZMH GZMB	1.34e-05	2	128	2	25495009
Pubmed	Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.	GZMH GZMB	1.34e-05	2	128	2	8137431
Pubmed	Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.	GZMH GZMB	1.34e-05	2	128	2	28798348
Pubmed	The granzyme B gene is highly polymorphic in wild mice but essentially invariant in common inbred laboratory strains.	GZMH GZMB	1.34e-05	2	128	2	17661907
Pubmed	A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis.	GZMH GZMB	1.34e-05	2	128	2	15356127
Pubmed	Role of Bid-induced mitochondrial outer membrane permeabilization in granzyme B-induced apoptosis.	GZMH GZMB	1.34e-05	2	128	2	16405654
Pubmed	MEKK2 mediates aberrant ERK activation in neurofibromatosis type I.	NF1 MAP3K2	1.34e-05	2	128	2	33177525
Pubmed	Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.	GZMH GZMB	1.34e-05	2	128	2	22792290
Pubmed	Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII.	GZMH GZMB	1.34e-05	2	128	2	3264185
Pubmed	Inhibitory Effect of Zinc on Colorectal Cancer by Granzyme B Transcriptional Regulation in Cytotoxic T Cells.	GZMH GZMB	1.34e-05	2	128	2	37298408
Pubmed	Lymphotoxin beta receptor is required for the migration and selection of autoreactive T cells in thymic medulla.	AIRE LTBR	1.34e-05	2	128	2	18056347
Pubmed	Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice.	GZMH GZMB	1.34e-05	2	128	2	23663075
Pubmed	Cloning of a gene that encodes a new member of the human cytotoxic cell protease family.	GZMH GZMB	1.34e-05	2	128	2	2193684
Pubmed	Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells.	GZMH GZMB	1.34e-05	2	128	2	24113190
Pubmed	A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human alpha/delta T-cell receptor locus.	GZMH GZMB	1.34e-05	2	128	2	2300587
Pubmed	Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway.	GZMH GZMB	1.34e-05	2	128	2	17179148
Pubmed	Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling.	GZMH GZMB	1.34e-05	2	128	2	33674611
Pubmed	Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.	GZMH GZMB	1.34e-05	2	128	2	7566124
Pubmed	Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.	GZMH GZMB	1.34e-05	2	128	2	26392464
Pubmed	Differential cleavage of viral polypeptides by allotypic variants of granzyme B skews immunity to mouse cytomegalovirus.	GZMH GZMB	1.34e-05	2	128	2	32473350
Pubmed	Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicity.	GZMH GZMB	1.34e-05	2	128	2	21964027
Pubmed	Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization.	GZMH GZMB	1.34e-05	2	128	2	27716898
Pubmed	Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension.	GZMH GZMB	1.34e-05	2	128	2	29445095
Pubmed	Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.	RASA1 NF1	1.34e-05	2	128	2	12730209
Pubmed	Ltbetar signaling does not regulate Aire-dependent transcripts in medullary thymic epithelial cells.	AIRE LTBR	1.34e-05	2	128	2	18566406
Pubmed	Granzyme B Disrupts Central Metabolism and Protein Synthesis in Bacteria to Promote an Immune Cell Death Program.	GZMH GZMB	1.34e-05	2	128	2	29107333
Pubmed	Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes.	GZMH GZMB	1.34e-05	2	128	2	25367158
Pubmed	Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2.	GZMH GZMB	1.34e-05	2	128	2	2007574
Pubmed	Maternal diesel particle exposure promotes offspring asthma through NK cell-derived granzyme B.	GZMH GZMB	1.34e-05	2	128	2	32407293
Pubmed	GLTSCR1 coordinates alternative splicing and transcription elongation of ZO1 to regulate colorectal cancer progression.	BICRA TJP1	1.34e-05	2	128	2	35218185
Pubmed	Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.	GZMH GZMB	1.34e-05	2	128	2	22236998
Pubmed	Lymphotoxin β receptor regulates the development of CCL21-expressing subset of postnatal medullary thymic epithelial cells.	AIRE LTBR	1.34e-05	2	128	2	23585674
Pubmed	Differential expression of granzyme B and C in murine cytotoxic lymphocytes.	GZMH GZMB	1.34e-05	2	128	2	19414782
Pubmed	Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability.	GZMH GZMB	1.34e-05	2	128	2	24791744
Pubmed	Activated mouse B cells lack expression of granzyme B.	GZMH GZMB	1.34e-05	2	128	2	22427643
Pubmed	Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.	GZMH GZMB	1.34e-05	2	128	2	16280358
Pubmed	Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis.	GZMH GZMB	1.34e-05	2	128	2	7493755
Pubmed	Mediation of the DCC apoptotic signal by DIP13 alpha.	DCC APPL1	1.34e-05	2	128	2	12011067
Pubmed	Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity.	GZMH GZMB	1.34e-05	2	128	2	19136373
Pubmed	Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells.	GZMH GZMB	1.34e-05	2	128	2	34183776
Pubmed	Granzyme B Contributes to Barrier Dysfunction in Oxazolone-Induced Skin Inflammation through E-Cadherin and FLG Cleavage.	GZMH GZMB	1.34e-05	2	128	2	32504614
Pubmed	Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions.	GZMH GZMB	1.34e-05	2	128	2	15699143
Pubmed	Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.	TSC1 BLM	1.34e-05	2	128	2	16288003
Pubmed	Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression.	GZMH GZMB	1.34e-05	2	128	2	19915065
Pubmed	Granzyme B inhibition reduces disease severity in autoimmune blistering diseases.	GZMH GZMB	1.34e-05	2	128	2	33436591
Pubmed	A human MAP kinase interactome.	USP53 TCF20 ABI3BP KIF26B BICRA NUP214 SETDB1 SH3D19 MAP2K1 MAP3K2	1.35e-05	486	128	10	20936779
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SETD1A TCF20 EP400 NBN CHD2 DBN1 BLM TJP1 TPX2	1.63e-05	394	128	9	27248496
Pubmed	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	PTK2B NF1 TJP1 APPL1 MAP2K1	1.71e-05	86	128	5	10862698
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	APC2 GPR37L1 AIRE CLIC6 ZEB2 SETDB1 HEATR6 TJP1 SH3D19 SENP6 DLAT CD74 APPL1 WDFY3 REPS2 KDM6A	2.10e-05	1285	128	16	35914814
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	WASF3 DICER1 DIS3 ADCY9 ZNF518A APPL1 WDFY3	2.10e-05	225	128	7	12168954
Pubmed	FoxN1 mediates thymic cortex-medulla differentiation through modifying a developmental pattern based on epithelial tubulogenesis.	AIRE TNFRSF11A TJP1	2.14e-05	15	128	3	31552487
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP53 SETD1A DLG5 EP400 SPART DICER1 DIS3 ADCY9 SENP6 IGSF1	2.78e-05	529	128	10	14621295
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TCF20 SF3A1 CHD2 NUP214 DICER1 DIS3 HP1BP3 BLM NF1 TJP1 DLAT	3.14e-05	653	128	11	22586326
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPRN SEC24A NBN TSC1 ADCY9 BLM RINT1 MTMR4 NDC1 PTPRE TJP1 MAPK11 KDM6A TP53BP2	3.39e-05	1049	128	14	27880917
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A TCF20 EP400 NBN DBN1 TJP1 SH3D19 TPX2 KDM6A TP53BP2	3.80e-05	549	128	10	38280479
Pubmed	Wilms Tumor Predisposition	DICER1 BLM NF1	3.82e-05	18	128	3	20301471
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A EP400 NUP214 DICER1 BLM SETDB1 NF1 TPX2 ASCC2	3.87e-05	440	128	9	34244565
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETD1A GNL3L TCF20 EP400 POLD2 NOB1 TSC1 CHD2 NUP214 DIS3 BLM NF1 MRPS15 DLAT WDFY3 TP53BP2	3.91e-05	1353	128	16	29467282
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	NLRP1 DICER1 DIS3 WDFY3 MYRF	3.91e-05	102	128	5	10231032
Interaction	YWHAB interactions	TFEB DLG5 KIF26B SEC24A SPEG WASF3 KAT6A TSC1 VPS13D MTMR4 NF1 DCP1B TJP1 SH3D19 CD74 APPL1 MAP2K1 FGD6 SH3RF3 TP53BP2 MAP3K2	1.08e-06	1014	125	21	int:YWHAB
Interaction	YWHAH interactions	USP53 TFEB DLG5 TCF20 KIF26B SEC24A SPEG TSC1 VPS13D MTMR4 NF1 DCP1B TJP1 SH3D19 APPL1 MAP2K1 FGD6 SH3RF3 TP53BP2 MAP3K2	1.44e-05	1102	125	20	int:YWHAH
Interaction	YWHAZ interactions	TFEB DLG5 KIF26B SEC24A SPEG WASF3 KAT6A TSC1 VPS13D MTMR4 NF1 DCP1B TJP1 SH3D19 DLAT CD74 APPL1 WDFY3 MAP2K1 FGD6 TP53BP2 MAP3K2	1.89e-05	1319	125	22	int:YWHAZ
GeneFamily	Chloride intracellular channels	CLIC6 CLIC2	3.01e-04	6	82	2	307
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	MTMR4 WDFY3 FGD6	3.69e-04	31	82	3	81
Coexpression	GSE3982_MAST_CELL_VS_TH1_DN	GNL3L RBL1 HP1BP3 BLM HIVEP3 NF1 GZMB TPX2	5.40e-06	198	126	8	M5454
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	RASA1 SPEG KAT6A CHD2 FBXL20 KDM6A IL6ST	4.52e-07	162	128	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CRYBG2 SYTL2 MUC5B CLIC6 DBN1 IGSF1 MYRF	6.77e-07	172	128	7	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	CHD2 ZEB2 NF1 KDM6A IL6ST TP53BP2 MAP3K2	1.23e-06	188	128	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Hematolymphoid-Microglia-TYROBP----L1-3\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCell	Hematolymphoid-Microglia-TYROBP--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCell	Hematolymphoid-Microglia-TYROBP-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	3bba5219453322198e8fdb0921d5f8c403598751
ToppCell	Hematolymphoid-Microglia\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	21bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCell	Hematolymphoid-Microglia-TYROBP---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCell	Hematolymphoid-Microglia-TYROBP\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	USP53 ZEB2 HIVEP3 PTPRE CD74 SH3RF3 IL6ST	1.85e-06	200	128	7	33036d21c1c82109284473a515c4f890b33fdd5c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD1A CRYBG2 RDH10 ZEB2 GZMH GZMB	6.73e-06	159	128	6	57df5c9b678a15eb5e025e1a80de2e6769cc13d5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZEB2 PTPRE KLF1 GZMH GZMB CD74	7.23e-06	161	128	6	bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da
ToppCell	droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 DOCK5 PTK2B PTPRE XIRP2 MAP2K1	1.16e-05	175	128	6	c8cfe0ac0c1ac447c626a623cc49692a0b177a1c
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 DOCK5 PTK2B PTPRE XIRP2 MAP2K1	1.16e-05	175	128	6	61fbd8f685d3daad46449e4c0386a38886496566
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TPRN SYTL2 ADCY9 MTMR4 MRPS15 REPS2	1.28e-05	178	128	6	89f0537459a321ded956bf70ad56fefc0854f8b0
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KIF26B PCLO MUC5B DCC XIRP2	1.55e-05	184	128	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KIF26B PCLO MUC5B DCC XIRP2	1.55e-05	184	128	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 KIF26B PCLO MUC5B DCC XIRP2	1.55e-05	184	128	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYTL2 DBN1 ZEB2 DOCK5 GZMH GZMB	1.69e-05	187	128	6	d17352f769c3c66601b65d060626eecff41b0482
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL15A1 ABI3BP ZEB2 XIRP2 SH3D19 KIAA1755	1.85e-05	190	128	6	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RASA1 ANKUB1 ZEB2 MAP2K1 KDM6A IL6ST	2.03e-05	193	128	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 FAT4 ABI3BP DBN1 SH3D19 KIAA1755	2.15e-05	195	128	6	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	(1)_T_cells-(1)_T_CD8_CTL\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TFEB ZEB2 GZMH GZMB CD74 MYRF	2.21e-05	196	128	6	ad9b0651cb2a15b750e453b2dcf782bca08b4fe7
ToppCell	mLN-T_cell-gd_T\|T_cell / Region, Cell class and subclass	KIF26B SYTL2 ZEB2 SH3D21 BLM TPX2	2.21e-05	196	128	6	8f476408cd5a4ea9d25c763c66565343d7989b38
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WASF3 DOCK5 PTPRE TJP1 REPS2 MYRF	2.27e-05	197	128	6	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	Severe-CD8+_T_activated\|Severe / Disease group and Cell class	DBN1 DOCK5 PTK2B GZMH GZMB CD74	2.27e-05	197	128	6	bb1e3e1d841c2c7141eb1099e7755860b168b6fc
ToppCell	Severe-CD8+_T_activated\|World / Disease group and Cell class	DBN1 DOCK5 PTK2B GZMH GZMB CD74	2.34e-05	198	128	6	5ff98c9b6c8c6863767b76c7745f263568f86acc
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND5B AMPD1 SEC24A DCC ENAM PTK2B	2.34e-05	198	128	6	567fcf882c8612356946240843525b786f3c8dbe
ToppCell	myeloid-Dendritic_cell-Conventional_dendritic_cell\|World / Lineage, cell class and subclass	ZEB2 ENHO PTPRE CLIC2 CD74 MAP2K1	2.34e-05	198	128	6	2ec42643200aa9feb33e2b87570f276fbad21cad
ToppCell	myeloid-Dendritic_cell\|World / Lineage, cell class and subclass	ZEB2 ENHO PTPRE CLIC2 CD74 MAP2K1	2.34e-05	198	128	6	240fff8264caeb7d1efcbccb187fe93744559bbc
ToppCell	Immune-monocyte\|World / Lineage, Cell type, age group and donor	NLRP1 ZEB2 DOCK5 PTK2B PTPRE MAP2K1	2.34e-05	198	128	6	d3622da252fd580f1dc5c7478a8e23df5ec083cf
ToppCell	mLN-T_cell-CD8_T\|T_cell / Region, Cell class and subclass	SYTL2 DBN1 ZEB2 GZMH GZMB CD74	2.47e-05	200	128	6	650916c6d2bcf00315c7a21088cb63f37bf24346
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	DLG5 TSC1 ZNF518A DLAT KDM6A	4.44e-05	135	128	5	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TFEB ANKUB1 TPRN SPTLC1 MYRF	4.77e-05	137	128	5	b03f19b233c1c809f2cd2b4a7642eeaf254a6289
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GZMH GZMB INTS9 ABCC10	7.20e-05	77	128	4	ebb1a537751739232820a60f88911877fc683855
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL15A1 GRK6 TPX2 MAPK11 MYRF	8.05e-05	153	128	5	c4dcdcaa672929c1da870e9fb8ada1bb030ad12f
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 PRR22 MUC5B MAPK11 MYBPC3	8.56e-05	155	128	5	62b59cb32b12bd55b19e98786a866d788fc9e4bf
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZEB2 DOCK5 KLF1 GZMH GZMB	1.02e-04	161	128	5	a480107b1c7773f2081afca2657e0b7fc88a5645
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AMPD1 ANKUB1 DCC SH3D21 ENAM	1.12e-04	164	128	5	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-dendritic_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DOCK5 ENHO PTPRE CLIC2 REPS2	1.12e-04	164	128	5	3088d5fa240d2f4a6e21281f7ac932aea2f9af49
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AMPD1 ANKUB1 DCC SH3D21 ENAM	1.12e-04	164	128	5	e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell	control-Myeloid-pDC\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CCDC168 ZEB2 PTPRE GZMB SH3RF3	1.15e-04	165	128	5	243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DOCK5 ENHO PTPRE CLIC2 REPS2	1.18e-04	166	128	5	479391aa6c09aa070b716128ab51b8fec0aea22d
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICRA BLM NDC1 MAPK11 ABCC10	1.21e-04	167	128	5	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	Control-Lymphocytic_B-B_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND5B NLRP1 PTK2B CLEC17A CD74	1.21e-04	167	128	5	a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312
ToppCell	Control-Lymphocytic_B\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND5B NLRP1 PTK2B CLEC17A CD74	1.21e-04	167	128	5	956da82394fd6a9f45fc2031796f12cc889542cd
ToppCell	Control-Lymphocytic_B-B_cells-B-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND5B NLRP1 PTK2B CLEC17A CD74	1.21e-04	167	128	5	69ed8a4a507190a1a66c4baf1f3e9be21ada39d8
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 DOCK5 PTK2B PTPRE MAP2K1	1.25e-04	168	128	5	d823979335ac6b5d1f062ebb741c759d2f919dbf
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP3 WASF3 RDH10 MUC5B CLIC6	1.25e-04	168	128	5	b275e951ff7109e36da22fc17bd4516f9b9432c4
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP3 WASF3 RDH10 MUC5B CLIC6	1.25e-04	168	128	5	0757a5af953901a8faed5774ffec4755fc9c0a6e
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENPP3 WASF3 RDH10 MUC5B CLIC6	1.25e-04	168	128	5	a0dbe2ee697e29b32aa5f8326445e067ff66c154
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_C\|368C / Donor, Lineage, Cell class and subclass (all cells)	BICRA SPEG BLM DOCK5 GZMH	1.25e-04	168	128	5	0372c06b70f0ba95bf8cd1363ca7c5f31207f094
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 NBN DOCK5 PTK2B PTPRE	1.25e-04	168	128	5	4b5be7c6662eceddf90a65015f12908278d1664e
ToppCell	Int-URO-Lymphocyte-B-B_intermediate\|Int-URO / Disease, Lineage and Cell Type	DENND5B MS4A10 CD74 ACSM6 MYRF	1.25e-04	168	128	5	5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 NBN DOCK5 PTK2B PTPRE	1.25e-04	168	128	5	689c41f6e9f65381570991cc311cba49a57ec955
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 DOCK5 PTK2B PTPRE MAP2K1	1.25e-04	168	128	5	f377ff4c066a9857ad14d245e56325ad220e22e1
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 NBN DOCK5 PTK2B PTPRE	1.28e-04	169	128	5	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PALMD ZEB2 GZMH CD74 TP53BP2	1.28e-04	169	128	5	17568e7aacfdcd96c469bae57d5ffad04954e9bd
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDM1 NBN DOCK5 PTK2B PTPRE	1.28e-04	169	128	5	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DLG5 BICRA GPR37L1 DICER1 MTMR4	1.32e-04	170	128	5	0f215911b5880eeffeb43230f7eeaf55b612eaf2
ToppCell	droplet-Kidney-KIDNEY-1m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEB TNFRSF11A HIVEP3 NDC1 PTPRE	1.36e-04	171	128	5	d9ad6a3bce3556abd24af1630bf4a99594437c3a
ToppCell	normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	ZEB2 GZMH GZMB CD74 NUTM2F	1.43e-04	173	128	5	1e8a43ff32eab95857c794e0bf4f0b0dba155b4a
ToppCell	IIF-Myeloid-pDC\|IIF / Disease, Lineage and Cell Type	KIF26B SLC9C2 ENAM PTPRE GZMB	1.51e-04	175	128	5	35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc
ToppCell	BAL-Control-cDC_11\|Control / Compartment, Disease Groups and Clusters	CRYBG2 DBN1 PTPRE FGD6 FLACC1	1.51e-04	175	128	5	daf014e15a354956e9149c83fd89d0af0d07eb00
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	SH3D21 DOCK5 ENHO CLIC2 CD74	1.55e-04	176	128	5	72a3bbab0540ae3e3c94b9573cdb9298a024dbc4
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	DBN1 SH3D21 PTPRE CLIC2 CD74	1.55e-04	176	128	5	195393b38f1335f2cb96125616d75c164a6026c2
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYTL2 TNFRSF11A PTPRE GZMH GZMB	1.59e-04	177	128	5	47813ad05527ea583e736b54b7a48f7ad90c3aef
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SNPH PCLO MDM1 HEATR6 ENHO	1.64e-04	178	128	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD1A TSC1 BLM TPX2 SH3RF3	1.68e-04	179	128	5	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 SYTL2 RDH10 CHD2 MUC5B	1.68e-04	179	128	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	normal_Lymph_Node-Myeloid_cells-CD141+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	DBN1 DOCK5 PTPRE CLIC2 LTBR	1.68e-04	179	128	5	ec995ccd6e1dbd06287ad836c232d9aed1cf94a8
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPRN SYTL2 ADCY9 MTMR4 REPS2	1.72e-04	180	128	5	710526abedc8e0f9ba19ad69220df4c9468ada8f
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 ABI3BP PALMD MAPK11 SH3RF3	1.72e-04	180	128	5	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYTL2 ZEB2 PTPRE GZMH GZMB	1.77e-04	181	128	5	12ff56fa2949c8d53360cdf2cacfd326e65b54aa
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR22 ZEB2 DOCK5 HEATR6 TPX2	1.77e-04	181	128	5	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FAT4 ABI3BP GCM1 ZEB2 HIVEP3	1.81e-04	182	128	5	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND5B AMPD1 ENAM CLEC17A CD74	1.81e-04	182	128	5	5f1f10c845b73d1f69794277925ef847ff23ac2d
ToppCell	CTRL-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	WASF3 TNFRSF11A ENHO CLIC2 GZMB	1.81e-04	182	128	5	ee137574b8f0e684a4a7cb26226877c471cae433
ToppCell	(00)_Basal-(0)_uninjured\|(00)_Basal / shred by cell type and Timepoint	ABI3BP MUC5B CLIC6 PTPRE IL6ST	1.81e-04	182	128	5	c02c9cab4389d80f318f4bb8d703c1e719672624
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP TNFRSF11A DOCK5 HIVEP3 PTPRE	1.81e-04	182	128	5	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP TNFRSF11A DOCK5 HIVEP3 PTPRE	1.81e-04	182	128	5	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP TNFRSF11A DOCK5 HIVEP3 PTPRE	1.81e-04	182	128	5	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	SYTL2 DBN1 ZEB2 GZMH GZMB	1.86e-04	183	128	5	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int\|lung / Disease (COVID-19 only), tissue and cell type	DENND5B SEC24A DCC BLM ENAM	1.91e-04	184	128	5	480595a0e2e6aa2a77b7daa36490ae3af3d8dfee
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD1 DLG5 ABI3BP RDH10 GPR37L1	1.91e-04	184	128	5	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	FAT4 ABI3BP ZEB2 APPL1 IL6ST	1.91e-04	184	128	5	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD1 DLG5 ABI3BP RDH10 GPR37L1	1.91e-04	184	128	5	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B ANKUB1 AIRE ENAM CD74	1.91e-04	184	128	5	42cadfdb5d29a50bd7e901ddd14d42b39e8474f0
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	CRYBG2 SYTL2 ZEB2 GZMH GZMB	1.91e-04	184	128	5	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	Leuk-UTI-Other-RBC\|Leuk-UTI / Disease, Lineage and Cell Type	SLC9C2 ENAM PTPRE GZMB CD74	1.96e-04	185	128	5	5b5dd856d6efc0539d92533cff134bbc3f98be45
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND5B AMPD1 SEC24A DCC ENAM	1.96e-04	185	128	5	3b77bc49cd3740acc025e162a36282ac09e12198
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCLO TNFRSF11A PTPRE XIRP2 CLIC2	1.96e-04	185	128	5	241ea1e178fffef9e7df971de739e794332d5173
ToppCell	LPS_only\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHD2 HIVEP3 PTK2B CD74 TP53BP2	1.96e-04	185	128	5	a72ccb147ca505880e2da8f6a70b9d570464a691
ToppCell	Leuk-UTI-Other\|Leuk-UTI / Disease, Lineage and Cell Type	SLC9C2 ENAM PTPRE GZMB CD74	1.96e-04	185	128	5	895e8087e97ac0eab3446385e6e0dd24bea7f42c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF26B SYTL2 DBN1 GZMH GZMB	2.01e-04	186	128	5	facc1bd8920003ad03d1893c32fc606d82b4d50a
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi\|lung / Disease (COVID-19 only), tissue and cell type	DENND5B SEC24A DCC BLM ENAM	2.01e-04	186	128	5	66676d9395172de5707e204826a1c9f73b448cca
ToppCell	Children_(3_yrs)-Immune-B_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DENND5B TFEB ENAM CLEC17A CD74	2.01e-04	186	128	5	aa576748921a318798b911a611f05319b95e8d5e
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYTL2 ZEB2 PTPRE GZMH GZMB	2.01e-04	186	128	5	c984e5729958237b101df96d1c89a236faacded6
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 ABI3BP PALMD MAPK11 SH3RF3	2.06e-04	187	128	5	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TCF20 SLC6A16 WDFY3 FGD6 SH3RF3	2.06e-04	187	128	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B NDC1 KLF1 TJP1 REPS2	2.06e-04	187	128	5	c81d11d9fdc22dc39222f62c2888025c2e8c3e65
Drug	Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	FAT4 NLRP1 PALMD PTK2B SETDB1 NF1 SENP6 MAPK11 IL6ST	1.57e-06	194	128	9	4200_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	BICRA MDM1 NUP214 DBN1 ADCY9 SENP6 APPL1 WDFY3 MAPK11	1.63e-06	195	128	9	1649_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A	DENND5B ABI3BP PCLO NUP214 TNFRSF11A DICER1 NF1 ASCC2 IGSF1	1.85e-06	198	128	9	4976_DN
Drug	H-F-V	ERV3-1 HIVEP3 APPL1 IL6ST	9.28e-06	24	128	4	CID005288549
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ABI3BP BICRA DOCK5 HIVEP3 VPS13D NF1 SENP6 IL6ST	1.44e-05	194	128	8	3539_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	ZNF444 CRYBG2 KAT6A HIVEP3 VPS13D WDFY3 MYRF IL6ST	1.55e-05	196	128	8	3789_DN
Drug	Methyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A	GNL3L RASA1 EP400 SEC24A GRK6 HEATR6 MRPS15 DLAT	1.67e-05	198	128	8	1619_DN
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A	SETD1A RBL1 GRK6 SPTLC1 SPART HIVEP3 VPS13D KDM6A	1.73e-05	199	128	8	6490_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	RBL1 SPEG GRK6 MUC5B PALMD ADCY9 KDM6A ABCC10	1.73e-05	199	128	8	7254_DN
Drug	AC1NSKHR	GRK6 NLRP1 MAPK11 MAP2K1	3.88e-05	34	128	4	CID005311362
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	SPART MUC5B DIS3 VPS13D NF1 PTPRE SENP6	9.54e-05	188	128	7	2239_UP
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	GNL3L PCLO MDM1 KAT6A SYTL2 IL6ST MAP3K2	9.54e-05	188	128	7	4545_DN
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	SNPH GRK6 MUC5B PALMD HIVEP3 NF1 SENP6	9.54e-05	188	128	7	5116_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZNF444 GNL3L KAT6A DICER1 DOCK5 MAPK11 IL6ST	9.86e-05	189	128	7	4304_DN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	DLG5 ZNF444 ABI3BP NLRP1 HP1BP3 DOCK5 FGD6	1.02e-04	190	128	7	7528_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	ABI3BP KAT6A NBN DICER1 HIVEP3 NF1 IL6ST	1.05e-04	191	128	7	4279_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HT_HG-U133A	MAN2A2 SPART SH3D21 ADCY9 CD74 MYRF MYBPC3	1.09e-04	192	128	7	6734_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	DENND5B GNL3L MAN2A2 SYTL2 SPTLC1 NF1 WDFY3	1.12e-04	193	128	7	3667_DN
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SETD1A KAT6A TNFRSF11A DOCK5 NF1 PTPRE IGSF1	1.12e-04	193	128	7	4973_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	DLG5 KAT6A SPART NF1 PTPRE WDFY3 MAPK11	1.16e-04	194	128	7	5448_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	MAN2A2 PCLO KAT6A DBN1 NF1 WDFY3 MAPK11	1.16e-04	194	128	7	4411_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SETD1A PCLO NBN VPS13D NF1 KDM6A IL6ST	1.16e-04	194	128	7	4727_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A	TFEB ZNF444 GNL3L EP400 SETDB1 MAPK11 IL6ST	1.16e-04	194	128	7	4317_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A	GNL3L SETDB1 VPS13D PTPRE SENP6 FGD6 IL6ST	1.16e-04	194	128	7	1699_DN
Drug	LY-171,883; Down 200; 1uM; MCF7; HG-U133A	SLC6A16 SPART PTK2B VPS13D NF1 KLK2 MYRF	1.16e-04	194	128	7	222_DN
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; HL60; HT_HG-U133A	USP53 COL15A1 PCLO SYTL2 SPART NLRP1 NUP214	1.20e-04	195	128	7	3082_UP
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	ZNF444 RBL1 BICRA SETDB1 SENP6 REPS2 KDM6A	1.20e-04	195	128	7	4229_DN
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	MAN2A2 VPS13D NDC1 NF1 SENP6 KDM6A MAP3K2	1.24e-04	196	128	7	2511_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A	DENND5B USP53 NLRP1 DOCK5 PTK2B MYRF IL6ST	1.24e-04	196	128	7	2961_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A	SETD1A FAT4 CRYBG2 MAN2A2 NLRP1 MUC5B ADCY9	1.24e-04	196	128	7	4482_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	EP400 GRK6 MDM1 NLRP1 PALMD HIVEP3 MAP3K2	1.24e-04	196	128	7	6295_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	ZNF444 SPEG PCLO HEATR6 FGD6 MYRF ABCC10	1.24e-04	196	128	7	7369_DN
Drug	Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	SNPH MAN2A2 BICRA KAT6A SETDB1 WDFY3 KDM6A	1.24e-04	196	128	7	6330_DN
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; HL60; HG-U133A	SEC24A SPTLC1 SPART ZEB2 HP1BP3 SENP6 DLAT	1.24e-04	196	128	7	1978_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A	DENND5B ZNF444 KAT6A NUP214 DICER1 NF1 MAPK11	1.24e-04	196	128	7	4987_DN
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	SLC6A16 SPEG AIRE SPART HIVEP3 CD74 IL6ST	1.24e-04	196	128	7	2306_UP
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	AMPD1 CRYBG2 PCLO MUC5B PTK2B NF1 CLIC2	1.28e-04	197	128	7	6099_UP
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	DLG5 CRYBG2 PCLO AIRE GCM1 NLRP1 DICER1	1.28e-04	197	128	7	6203_UP
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A	AIRE NLRP1 PALMD PTK2B NF1 MAPK11 IL6ST	1.28e-04	197	128	7	4249_UP
Drug	Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	APC2 AIRE HP1BP3 PTK2B VPS13D NF1 WDFY3	1.28e-04	197	128	7	3351_UP
Drug	Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	EP400 RBL1 SPEG SYTL2 PALMD SETDB1 NF1	1.28e-04	197	128	7	6727_DN
Drug	CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A	BICRA GRK6 WASF3 SPTLC1 MAPK11 MYRF MYBPC3	1.28e-04	197	128	7	7502_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	AMPD1 CRYBG2 SEC24A SPART NUP214 HIVEP3 MYBPC3	1.28e-04	197	128	7	6055_UP
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A	ZNF444 SNPH GRK6 HIVEP3 VPS13D PTPRE MAPK11	1.28e-04	197	128	7	5801_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	GNL3L MAN2A2 HIVEP3 NF1 SENP6 KDM6A IL6ST	1.28e-04	197	128	7	5815_DN
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	GNL3L GRK6 KAT6A ADCY9 DOCK5 VPS13D SENP6	1.28e-04	197	128	7	5685_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A	TFEB CRYBG2 MAN2A2 SEC24A KAT6A NUP214 DOCK5	1.28e-04	197	128	7	2237_UP
Drug	Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A	TFEB MAN2A2 GRK6 NUP214 HEATR6 NF1 REPS2	1.28e-04	197	128	7	5099_UP
Drug	Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A	GNL3L ABI3BP RBL1 SPART TNFRSF11A MAPK11 IL6ST	1.32e-04	198	128	7	5992_DN
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CRYBG2 NUP214 DIS3 HIVEP3 VPS13D NF1 MAPK11	1.32e-04	198	128	7	7473_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	RASA1 EP400 NBN DICER1 ADCY9 VPS13D WDFY3	1.32e-04	198	128	7	1070_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	AMPD1 FAT4 SNPH KIF26B BICRA KLF1 MAPK11	1.32e-04	198	128	7	5598_UP
Drug	Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A	ZNF444 PCLO SPART DOCK5 HIVEP3 VPS13D IL6ST	1.32e-04	198	128	7	1518_UP
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A	EP400 RBL1 PALMD ASCC2 REPS2 KDM6A ABCC10	1.32e-04	198	128	7	7244_DN
Drug	Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SETD1A ZNF444 SPART HIVEP3 NF1 KDM6A MAP3K2	1.36e-04	199	128	7	3307_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A	SETD1A ZNF444 SPEG SH3D21 SETDB1 MAPK11 MYRF	1.36e-04	199	128	7	4561_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A	GNL3L TNFRSF11A HP1BP3 DOCK5 NF1 PTPRE IL6ST	1.36e-04	199	128	7	4695_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A	USP53 AMPD1 KAT6A SPART NLRP1 DOCK5 KLK2	1.36e-04	199	128	7	2956_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	DENND5B FAT4 CRYBG2 COL15A1 SPEG HIVEP3 MYBPC3	1.36e-04	199	128	7	6024_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A	MAN2A2 SEC24A NLRP1 PALMD HIVEP3 VPS13D WDFY3	1.40e-04	200	128	7	6284_DN
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; HL60; HT_HG-U133A	DENND5B COL15A1 WASF3 NLRP1 ADCY9 REPS2 IL6ST	1.40e-04	200	128	7	6127_DN
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A	MAN2A2 RBL1 SPEG GRK6 NLRP1 PALMD DOCK5	1.40e-04	200	128	7	6298_DN
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	MAN2A2 ABI3BP SPEG AIRE HP1BP3 WDFY3 IL6ST	1.40e-04	200	128	7	2224_UP
Drug	wortmannin; Up 200; 0.01uM; ssMCF7; HG-U133A	SPART CHD2 RSPH6A DCC SH3D21 CD74 MYRF	1.40e-04	200	128	7	404_UP
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZNF444 BICRA KAT6A DOCK5 VPS13D IGSF1 KDM6A	1.40e-04	200	128	7	3442_DN
Drug	alpha-ketoisovalerate	KAT6A NUP214 HIVEP3 DLAT MAPK11	1.48e-04	89	128	5	CID000000049
Drug	phenylarsine oxide	RASA1 PTK2B TJP1 LTBR FBXL20 MAPK11 IL6ST MYBPC3	1.68e-04	275	128	8	CID000004778
Disease	granzyme b measurement	GZMH GZMB	1.08e-04	4	126	2	EFO_0020418
Disease	Noonan Syndrome	RASA1 NF1 MAP2K1	1.44e-04	24	126	3	C0028326
Disease	creatinine measurement	DENND5B TFEB AMPD1 KIF26B SPEG GRK6 PRR22 CHD2 DBN1 KIAA1755 FBXL20 REPS2 ABCC10	3.43e-04	995	126	13	EFO_0004518
Disease	grapefruit juice consumption measurement	PCLO DCP1B	3.75e-04	7	126	2	EFO_0010094
Disease	LEUKEMIA, ACUTE LYMPHOBLASTIC	NBN NUP214	4.98e-04	8	126	2	613065
Disease	Acute lymphoid leukemia	NBN NUP214	4.98e-04	8	126	2	cv:C0023449
Disease	response to risperidone	TNFRSF11A DOCK5 TJP1	5.75e-04	38	126	3	GO_0097336
Disease	Malignant neoplasm of breast	APC2 SPTLC1 NBN NUP214 DBN1 ZEB2 NF1 GZMB CD74 APPL1 REPS2 FLACC1 TP53BP2	7.00e-04	1074	126	13	C0006142
Disease	melanoma	FAT4 DCC PTK2B SETDB1 NF1 MAP2K1	7.05e-04	248	126	6	C0025202
Disease	glucagon-like peptide-1 measurement	BICRA ENAM	7.96e-04	10	126	2	EFO_0008465
Disease	spleen volume	TJP1 ASCC2 LTBR	8.28e-04	43	126	3	EFO_0600047
Disease	Colorectal Carcinoma	AMPD1 SF3A1 APC2 DCC ZEB2 HIVEP3 NF1 TPX2 KDM6A IL6ST	8.84e-04	702	126	10	C0009402
Disease	Medulloblastoma	KAT6A NBN KDM6A	1.29e-03	50	126	3	C0025149
Disease	Prostatic Neoplasms	COL15A1 WASF3 KAT6A NBN SETDB1 SENP6 KLK2 KDM6A IL6ST	1.35e-03	616	126	9	C0033578
Disease	Malignant neoplasm of prostate	COL15A1 WASF3 KAT6A NBN SETDB1 SENP6 KLK2 KDM6A IL6ST	1.35e-03	616	126	9	C0376358
Disease	alcohol use disorder (implicated_via_orthology)	RASA1 GRK6 CLIC6 CLIC2 KDM6A	1.53e-03	195	126	5	DOID:1574 (implicated_via_orthology)
Disease	acute lymphoblastic leukemia (is_implicated_in)	NBN NUP214 KDM6A	1.70e-03	55	126	3	DOID:9952 (is_implicated_in)
Disease	Neoplasm of uncertain or unknown behavior of bladder	TSC1 KDM6A	1.83e-03	15	126	2	C0496930
Disease	Benign neoplasm of bladder	TSC1 KDM6A	1.83e-03	15	126	2	C0154017
Disease	Carcinoma in situ of bladder	TSC1 KDM6A	1.83e-03	15	126	2	C0154091
Disease	RASopathy	NF1 MAP2K1	1.83e-03	15	126	2	cv:C5555857
Disease	Rhabdomyosarcoma	NBN DICER1	1.83e-03	15	126	2	C0035412
Disease	Malignant Neoplasms	DICER1 BLM MAP2K1 KDM6A	2.25e-03	128	126	4	C0006826
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	NBN NUP214 BLM	2.28e-03	61	126	3	C1961102
Disease	Familial Progressive Myoclonic Epilepsy	TSC1 CHD2	2.36e-03	17	126	2	C0751777
Disease	Atypical Inclusion-Body Disease	TSC1 CHD2	2.36e-03	17	126	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	TSC1 CHD2	2.36e-03	17	126	2	C0751778
Disease	Biotin-Responsive Encephalopathy	TSC1 CHD2	2.36e-03	17	126	2	C0751780
Disease	May-White Syndrome	TSC1 CHD2	2.36e-03	17	126	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	TSC1 CHD2	2.36e-03	17	126	2	C0751781
Disease	Carcinoma of bladder	TSC1 KDM6A	2.65e-03	18	126	2	C0699885
Disease	Action Myoclonus-Renal Failure Syndrome	TSC1 CHD2	2.65e-03	18	126	2	C0751779
Disease	Noonan-Like Syndrome With Loose Anagen Hair	RASA1 MAP2K1	2.95e-03	19	126	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	RASA1 MAP2K1	2.95e-03	19	126	2	C1843181
Disease	Cardio-facio-cutaneous syndrome	RASA1 MAP2K1	2.95e-03	19	126	2	C1275081
Disease	Costello syndrome (disorder)	RASA1 MAP2K1	2.95e-03	19	126	2	C0587248
Disease	DiGeorge syndrome (implicated_via_orthology)	KAT6A DICER1	2.95e-03	19	126	2	DOID:11198 (implicated_via_orthology)
Disease	citrulline measurement	KIF26B PTPRE	3.27e-03	20	126	2	EFO_0009777
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	DCC MYRF	3.60e-03	21	126	2	OBA_2045104
Disease	LEOPARD Syndrome	RASA1 MAP2K1	3.95e-03	22	126	2	C0175704
Disease	autism spectrum disorder (implicated_via_orthology)	TCF20 TSC1 CHD2 WDFY3	4.17e-03	152	126	4	DOID:0060041 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KPSSLGKPLPPYIVQ	ACSM6	386	Q6P461
SFYEHVNQKLPEPPP	ERV3-1	256	Q14264
EATPIPEAKLPPVYV	EP400	2271	Q96L91
PPPQKPSHEGSYLLQ	ENHO	61	Q6UWT2
PVRPPQLFKPLYSSH	CXorf66	206	Q5JRM2
KPPPKDNIPALVEEY	ASCC2	41	Q9H1I8
QQFIPVKRPIPHPAY	GZMB	86	P10144
VKRPIPHPAYNPKNF	GZMB	91	P10144
QQFIPVKRPIPHPAY	GZMH	86	P20718
VKRPIPHPAYNPKNF	GZMH	91	P20718
DNPPTFLSPKLTYIP	FAT4	2046	Q6V0I7
EAAVSKDEPKPLPYP	AMPD1	221	P23109
KDEPKPLPYPNLDTF	AMPD1	226	P23109
NKPVFYPKPPKTFAP	C7orf31	236	Q8N865
YPKPPKTFAPNTSLN	C7orf31	241	Q8N865
TAKPIPQIPHFPVYT	DICER1	806	Q9UPY3
LAPPRYPKLGTQHPE	CLIC6	551	Q96NY7
PVPTKPKQINLPYFG	TP53BP2	501	Q13625
TLVYKHLPAPPSAAP	AIRE	391	O43918
YPSPGVLFPKKEPDD	HP1BP3	416	Q5SSJ5
YIVNEPPPKLPSGVF	MAP2K1	316	Q02750
PTKVYKPCGPIQPAT	MUC5B	5361	Q9HC84
VKIPAALPVAAAPYP	RASA1	36	P20936
KQSKVYLPEPPFPHA	INTS9	351	Q9NV88
FSPGNLYIPVFPLPK	ABCC10	941	Q5T3U5
LYIPVFPLPKAAPNG	ABCC10	946	Q5T3U5
IAPHSQVYQPAKPTP	PALMD	466	Q9NP74
AIEPKVPYTPLLSQP	DCC	1356	P43146
PSGPKKYFPIPVEHL	PTPRE	106	P23469
PEPCALPEKPAVYTK	KLK2	231	P20151
TYQEVLSFKPPEPPK	MAPK11	341	Q15759
SGFHLPYKPKPPQET	NOB1	126	Q9ULX3
PLVPAPKNHNYLQPT	FLACC1	41	Q96Q35
YKQPLKPSGSEPPAE	HHLA3	6	Q9XRX5
VDKKPVPEPAYPILF	KIAA1755	131	Q5JYT7
VYTQKGVLPSPAPLP	KIF26B	1091	Q2KJY2
LYVPDPDPTKFPVNR	APPL1	261	Q9UKG1
LPKDKLNPPTPSIYL	KDM6A	931	O15550
NLLPQPPRSKYIHPD	POLD2	116	P49005
YCFADLAPQKPAPPL	POLD2	176	P49005
QLAPSPPKSPKVLYS	PCLO	3611	Q9Y6V0
VPYEKPLPDDISPQK	PCLO	3641	Q9Y6V0
YSLPPHQKVPLPSLS	DLAT	86	P10515
QFVRIHKPPPLTPLY	NLRP1	1271	Q9C000
KGLPVEPPPSYQSVI	MS4A10	216	Q96PG2
QPTNPKLPPHVSDYT	MAP3K2	576	Q9Y2U5
ATLPVSKIPKYPTNP	MDM1	611	Q8TC05
PNTFKRPQTPPKIDY	DLG5	976	Q8TDM6
YPTPLPQYDGRTPIK	HEATR6	286	Q6AI08
PTLQEKKVIPCPPFY	NUP214	221	P35658
ELCAKAPPPVFYNKP	DBN1	611	Q16643
PPSLEYIQAKDLFPP	MTMR4	6	Q9NYA4
PPPLPSSQKDYLSNK	MTMR4	676	Q9NYA4
YKDPDNPGRIALPKP	KAT6A	71	Q92794
YDNPNLIKPIPVKPS	DCP1B	191	Q8IZD4
LYNLKFQPPTLGPEP	APC2	86	O95996
PLPAYPATQKVLQDP	CEFIP	1266	Q711Q0
FYPKPTLLAQPGPVV	IGSF1	871	Q8N6C5
HINFDPVYKVKPNPP	IL6ST	211	P40189
APAPEPKALALQPVY	KLF1	156	Q13351
PPKPINRPFLKPSYA	BLM	1401	P54132
SLPPSYKDKPVPEQI	DOCK5	1436	Q9H7D0
YTLANPLNTPPHIKP	MT-CYB	256	P00156
SIYAPPNNRFKDKPP	GCNT7	256	Q6ZNI0
GEYKQPLPPLHPAVS	CHD2	1771	O14647
KPDQHFKPYLTPDLP	ENPP3	431	O14638
EYPRPIHPAGLQPTK	GPR37L1	66	O60883
PEKSDFPLLAPPTNY	CFAP107	126	Q8N1D5
QSHGPIFSKKYIPPP	CRYBG2	91	Q8N1P7
PFYQQLPLEPPAAKT	GCM1	336	Q9NP62
LYKAVTSQQPPPLPL	DENND5B	211	Q6ZUT9
FLKYEAATVPPPPAA	ADCY9	806	O60503
FLPDGEAKPYVPKEP	MAN2A2	816	P49641
PKEYLPYSLDNPSKP	ENAM	696	Q9NRM1
PLKVYPPLKGSFPEN	CD74	151	P04233
IQAYKPDDLKSPPFP	CCDC168	6371	Q8NDH2
KYRPPPQTNLLAPKL	PTK2B	721	Q14289
LEPPFKPDPQAIYCK	GRK6	461	P43250
IQPKPAGVLPPKLYQ	BICRA	351	Q9NZM4
AGVLPPKLYQLTPKP	BICRA	356	Q9NZM4
PKLYQLTPKPFAPAG	BICRA	361	Q9NZM4
LLPPPNPISSANYEK	COL15A1	1201	P39059
PYSKIPIFPLFPNVD	EFCAB3	236	Q8N7B9
ITYPPQKADAPAVSP	C3orf86	26	P0DN24
YPTDFLGPLPANPVK	DPP7	276	Q9UHL4
EQTLAPPRYPHLSPK	CLIC2	91	O15247
QPVYLPSKDGPKAPT	NUTM2F	326	A1L443
QPVYLPSKDGPKAPT	NUTM2G	326	Q5VZR2
DPPPSTLLKDYQNVP	MRPS15	66	P82914
KYSPESFNPALPAPI	RSPH6A	651	Q9H0K4
LQYVPEPVPGKKLPT	SYTL2	776	Q9HCH5
NPAFLKFHPYPPSVL	SPATA48	61	A4D263
SPPPVPGEVLKVQSY	TFEB	61	P19484
PDAKPPVNLLYNPTS	SLC6A16	426	Q9GZN6
FPDNFVLPPPPIKKL	SH3D21	116	A4FU49
PYPPLQEAGSIPVTK	SH3D19	86	Q5HYK7
TQSPGKYVLPPPKLN	TMEM185A	331	Q8NFB2
SKKQPPQIESFYPPL	NBN	186	O60934
IFQNPYEEPPKLPRS	RBL1	146	P28749
GSYPHPIPAKTLNPV	SEC24A	56	O95486
NIKVHAYFAPVTPPP	FBXL20	406	Q96IG2
KISFYIPPPATHTLP	GNL3L	396	Q9NVN8
GIKPPTPEQYLTPLQ	SNPH	66	O15079
KASKPLPPAPAPDEY	SF3A1	396	Q15459
EPFLPPLKPDYCVKQ	RDH10	261	Q8IZV5
HPAPPPSNYEILVKA	DIS3	691	Q9Y2L1
NYALAVKPTPPAPAL	SETD1A	1301	O15047
PPVPKDHPALNYNIV	SPTLC1	71	O15269
PPPQVAYSKERIPGK	SETDB1	701	Q15047
IKNTYLPQVPLPPVS	ANKUB1	441	A6NFN9
DYENSTPPYKDLPPK	CLEC17A	51	Q6ZS10
FCQNLPPPLPPKKYA	USP53	916	Q70EK8
LSQSPKKDSYVEPPP	XIRP2	2966	A4UGR9
LNLYHPPDPEKEVFP	PRR22	46	Q8IZ63
DLQEVPKLYPEFPPK	SPART	106	Q8N0X7
PPPYDHLFEVALPKT	TSC1	601	Q92574
QAVRPYKQEPSSPPL	ZNF444	151	Q8N0Y2
VSTPPVYPPKNVADL	WDFY3	816	Q8IZQ1
PPTLQPEYLQAAFPK	REPS2	361	Q8NFH8
RVPGKLAPPEVPQTY	SPEG	2676	Q15772
EPKQLPEKYSLPASP	RINT1	286	Q6NUQ1
IQPLPHAPPQGKALY	SH3RF3	251	Q8TEJ3
KEFYRPIPNPNPKLT	TEX37	51	Q96LM6
PPPLNILTPYRDDKK	WASF3	131	Q9UPY6
LEIHLVPYTPKFPTP	FGD6	301	Q6ZV73
KPYLPPPVSLFSFQH	HIVEP3	1136	Q5T1R4
PYEAGILDKKPPPRI	NF1	1421	P21359
IFIGPVEKLIVYPPP	SENP6	646	Q9GZR1
NEIFPKPPLYTFLPD	ZNF518A	1086	Q6AHZ1
PQDYAATLPKNPPPK	TCF20	1726	Q9UGU0
LYKKPPPFLELLPSP	nan	541	Q6ZUG5
SLPTHYQPEPAKAFP	ZNF469	656	Q96JG9
QKTVPSDPPYPSFLL	ZNF469	1461	Q96JG9
PKAHPYFPDLVQPLL	LTBR	281	P36941
PALPPKIFYIKQEPF	ZBTB9	276	Q96C00
EKQTPSLPEPKPVYA	TJP1	376	Q07157
APQAAKLPYLPHPAR	TPRN	466	Q4KMQ1
PKAIPPPTPDIYLHN	SLC9C2	851	Q5TAH2
AKPLYTALPPQSAFP	ZEB2	891	O60315
KYLIVVRPAPPPSQK	ABI3BP	91	Q7Z7G0
LLPHKPYPEVSQSEP	ABI3BP	581	Q7Z7G0
RKPPNEPHVYLPGLI	TNFRSF11A	201	Q9Y6Q6
YCPIIPNKSPSKGPL	PP2D1	481	A8MPX8
IKAQPVPHYGVPFKP	TPX2	511	Q9ULW0
KEVQDKDYPLTPPPS	VPS13D	1751	Q5THJ4
PRPGITYEPPNYKAL	MYBPC3	1161	Q14896
PIKAEPKAPYAPGTL	MYRF	121	Q9Y2G1
PKVLNSNPPPIIKYL	NDC1	316	Q9BTX1